_id
69130589ccc777a4e85d7aa2
Ticker
JANX
Name
Janux Therapeutics Inc
Exchange
NASDAQ
Address
10955 Vista Sorrento Parkway, San Diego, CA, United States, 92130
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.januxrx.com
Description
Janux Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies based on Tumor Activated T Cell Engager (TRACTr) and Tumor Activated Immunomodulator (TRACIr) platforms technology to treat patients with cancer. Its clinical candidates include JANX007, a prostate-specific membrane antigen or PSMA-TRACTr, which is in Phase 1 clinical trial in adults for the treatment of metastatic castration-resistant prostate cancer and the vasculature of other tumors; and JANX008, an epidermal growth factor receptor that is in Phase 1 clinical trial for the treatment of various solid cancers, including colorectal cancer, squamous cell carcinoma of the head and neck, non-small cell lung cancer, renal cell carcinoma, small cell lung cancer, pancreatic ductal adenocarcinoma, and triple-negative breast cancer. Janux Therapeutics, Inc. has strategic research collaboration agreement with Merck Sharp & Dohme Corp. to develop TRACTr product candidates. The company was incorporated in 2017 and is headquartered in San Diego, California.
Last Close
13.84
Volume
1523738
Current Price
14.175
Change
-0.15
Last Updated
2026-01-04T15:36:17.563Z
Image
data:image/webp;base64,UklGRsYIAABXRUJQVlA4WAoAAAAQAAAAPwAAPwAAQUxQSPEFAAANuS5E9D9EWLP9cyTJ1nO01lr5b89Bh8urtdagqquFBR8KlPw27zUgyY/9SRqwzXt5XvVnP5J81oA2IEg4UHyHlwNBwoAyoJfnJRETMAF/+ds+47PEf/g3wN/6V//sHz09fd4P/AIgW5wuW8DP/NDn/L2/0f/Jv3gD/p2RPsKF41+HM8RRI25pBPBbAkUaILmtaDSxf0GCxa0EoK8wmJIHR6d6QgPT4kv+0vxFErcWoOmrPiSgi8NUmCHflBYhee1/p4/bAWPjNW0c05Eg07u5uU6jJuSOC3faFBk2Lbkx4K99g5REAF71flerLcd6N1Ohu3vhRhvp18ChXGSo/uR9d8vm7e39HXy8ZkR0DmdZFMn+U5BWZnP0aaVnpDK0/YNp3CK3lYDOlwFVPZxNCViIIGS8zZevmS6jtlCWPk4aWQhF71dgBR2C/B1SEVkli7heXsY3/ZUpokPlNFyimAXYgRwSaeknFAYCjWkiMvpf+JbV0x7Oy/WEa4yg7vEMeF81TUMEWB8YU6C2eGy5Aq6LZ7lPrTYJEKMvmdT1zIGLo02thIpiASyqHMWFZYcKoCaEOczIMgVcl4NuDZRK2QbIyDI56JcWY6uxvizKhhroSCjKTDlzONfFTFy4WRwtL3NpY1ue91pfzCJzYygAKwPqXKdlpAu3b3XturbFgsvleUDEMUe6RPjaXtCcbuf8hLucXiIjgon15VmZRRlHskTYfSrLNtcULcXd5iTVncbleaSQUAhQKw4rysv1rV9Z3Lvvpm1mtSSlxkFqWNAdxkSX8oMUzIW7XaJrNmNp2SS9skU2RTgUdhk9nctEqZ27zqgqAA2VlUTB0XJ+KaO0CDKJzt3nmi0lXIFxnh2YjFbermX2hig9Z+5z2Sc1ZYXtHBcXWXLSzk9+Hk+JSy/c72RQwPRpLSr2CATB6H+utLniiHtqXQ3g/YyLrSJZyi6d39jWaPY92VjQarjYMUDnlWzZqDB1F+5ZHL1e5BICiP2ZufXix9dH8UBzqWGbG1+m6yXD0McDGSrhcLQbqPt2UXorvelBOAjkxokVAzkIHmQRTjUOLWR4OduSxQMtSoujAgOsQjT5YYQcwq1waiUF4mHK2M7tFZCP+PKsxA+lJBRK+57/DMxh/zP/NRTheCCjl0FJnz/ddw6fnj5VZgke7Cj7RGiq5wxgvUwoedBtt9WXVR+9K9SnZyY514cxLbG+ztv2biPmJM919f9LJAHbNr/OTNO9tOam/CT2OoRTr5k5GopYaR/XKCWCex2Y5Pz2wSclURkgpAxWeOwFpHofeq5yyS0u+/klBiMRLXoPYBuvUdpknj6+q7aMtRY0ZfSXD/1IkRIKQDs3v6uRTY76Nk3tNNk64oxKeRyMJ9UPP5q4eXysqOsaozXy4vkKoNAxIw5kYjXOUJJt58SlN1sF0SxBObC4QQBaZipka7MiFw9ZN7S5DYJloQU5JlbrJAEsj28Uok0UZtoiiZvXVmZohkWdqRDv6oQ4Vc/eo2Mm4G2QjeDEtg5ltDbVy3XUXLqv68vjaYtVHPYG1LWMbG79BAhWpabRL4+ja+SuqJy81XB0bwD7JkTbOVWULFPW8xOv76Vk1LEfyZBpzxdcoghgV0C25OTpYia1rMvK2/tOyxHXp/PAoEl5sUrUeAR8ydJCI06DtVmZCdBbtLa2WMrcvF2wAldFPANln6Ipc79VErZdzjvro8SIdJH16R8JdyIoOgN7bzmkFtx28dzrSCs2r0/nJVujDMSP/ZIxUe0z4L1q2ZYMANk6olCD/fKiZVso+NIeqz0R8F1QKHY/cxBdXhZzaMRRC+D8NmfNlitQastSYkQYGxRjHHSlhOZj4jSm17DDnir0s5Es/TE0xFFrrUvkNL3jqLhRHM2FrLN8fQqiK4KwfwVxvMwvfVkmLSt3PT3PMbu17THKuoOEbW6O0uVpa++4c8HeO48MFwAHMG+QQaogQGnudbmUURQtxGEIg0IY04YyavG9MBa1UuYw4BDawBhCHme3PnO/2Tdl7PKBAAAAVlA4IK4CAACQDQCdASpAAEAAPq1InkmpJCMhLBgPMSAViWwNuEUm/gi/ZVXs35K/jN1YPIca14DbN+YD7ZveZ9G28Fc/D7E/7ffud7WRgYmaEuyvnIefMat7vk/XFDFCAZLs8JpVHJvkrlShlKa4Jg1tqFN+iKGPMeJj0AAA/vDZE2OeHA8dJLKA/3N+gDvfM6wi46sAfV7fJKTaltTsk4PWjQqlUMUF8TGGT8/CdkEh25++89hNrxZ/POC8LuXyvkwEjeWXi1INEKC7JflLu7S14ru2eRG5NvL2XRTYDbt9QEAQ0Fw7oShVX2FgaKexav3oCPy4053e9BowfLYkQHRMa+5uuv8HQv7OpEaGASNaNnIyI8O0/5bkIPMewAWMZn3FhKArT+7u2GtPHm7sq1T0YI18NKLYn0pSRoFdR9kbe5jJs590vgzfCxShGDzfrpo8CercLhmuhfarG30Ex98TBLIp418KdKVINl18BsrCPHw3DwBLMweAHx41O7yZfSP+vLe7wZD0SAnh43YxSLuDoYvNOhou8wsp+un8v0ef/vhvcbpflgdlO4QaZ+f/nNljBiXfIlWuAba7BPS0KEO0QilvHaljCUwKZDvSDvQx8JtJ0Tfv9/GxuTZb1cBeYu6XoxbKoZguKGk9MeuAvhGfe4OK4jTeKnUvCXS7CKEbIlfYc9Rvjg694y8gw2ECnYGRrs/YU6sHX5XZri0/VqDV9dysegOf/GFCCHOD1sNA9IYwxgSHYS31cUobTcPdy55XLlbxhKDT3moh4MnmFvK35fIvJ6xHrADWw55SEE5M6M+znvmB9fU7GAaKOC/yTwwX/cnD8kMtCFdVSpxXwoAuYdMl2OpAf6AUW/J0AUxhoh07YTrRwK84/G8RrSX55kFIwfGjAEXxsztPf6W5t+kuORgAAA==
Ipo Date
2021-06-11T00:00:00.000Z
Market Cap
821017536
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.3411666666666667
Sentiment Sources
6
Rating
4.7692
Target Price
65.1177
Strong Buy
11
Buy
1
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
10000000
Cost Of Revenue
501000
Gross Profit
9499000
Operating Expenses
44750000
Operating Income
-35251000
Interest Expense
-
Pretax Income
-24313000
Net Income
-24313000
Eps
-0.3919954127201568
Dividends Per Share
-
Shares Outstanding
60147807
Income Tax Expense
-
EBITDA
-23812000
Operating Margin
-352.51
Total Other Income Expense Net
10938000
Cash
48389000
Short Term Investments
940604000
Receivables
6315000
Inventories
-
Total Current Assets
998086000
Property Plant Equipment
23237000
Total Assets
1024766000
Payables
3395000
Short Term Debt
2280000
Long Term Debt
-
Total Liabilities
48211000
Equity
976555000
Bs_currency_symbol
USD
Depreciation
501000
Change In Working Capital
6535000
Cash From Operations
-12856000
Capital Expenditures
93000
Cash From Investing
8306000
Cash From Financing
493000
Net Change In Cash
-4057000
Cf_currency_symbol
USD
PE
-
PB
0.90029310676306
ROE
-2.4896703206680626
ROA
-2.3725416338949574
FCF
-12949000
Fcf Percent
-1.2949
Piotroski FScore
1
Health Score
34
Deep Value Investing Score
4.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2
Net Net Investing Score
4.5
Quality Investing Score
2.5
Value Investing Score
5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
10000000
Quarters > 0 > income Statement > cost Of Revenue
501000
Quarters > 0 > income Statement > gross Profit
9499000
Quarters > 0 > income Statement > operating Expenses
44750000
Quarters > 0 > income Statement > operating Income
-35251000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-24313000
Quarters > 0 > income Statement > net Income
-24313000
Quarters > 0 > income Statement > eps
-0.3919954127201568
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
62023685
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-23812000
Quarters > 0 > income Statement > operating Margin
-352.51
Quarters > 0 > income Statement > total Other Income Expense Net
10938000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
48389000
Quarters > 0 > balance Sheet > short Term Investments
940604000
Quarters > 0 > balance Sheet > receivables
6315000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
998086000
Quarters > 0 > balance Sheet > property Plant Equipment
23237000
Quarters > 0 > balance Sheet > total Assets
1024766000
Quarters > 0 > balance Sheet > payables
3395000
Quarters > 0 > balance Sheet > short Term Debt
2280000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
48211000
Quarters > 0 > balance Sheet > equity
976555000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-24313000
Quarters > 0 > cash Flow > depreciation
501000
Quarters > 0 > cash Flow > change In Working Capital
6535000
Quarters > 0 > cash Flow > cash From Operations
-12856000
Quarters > 0 > cash Flow > capital Expenditures
93000
Quarters > 0 > cash Flow > cash From Investing
8306000
Quarters > 0 > cash Flow > cash From Financing
493000
Quarters > 0 > cash Flow > net Change In Cash
-4057000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.3919954127201568
Quarters > 0 > ratios > PB
0.90029310676306
Quarters > 0 > ratios > ROE
-2.4896703206680626
Quarters > 0 > ratios > ROA
-2.3725416338949574
Quarters > 0 > ratios > FCF
-12949000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-1.2949
Quarters > 0 > health Score
34
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
541000
Quarters > 1 > income Statement > gross Profit
-541000
Quarters > 1 > income Statement > operating Expenses
45118000
Quarters > 1 > income Statement > operating Income
-45118000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-33858000
Quarters > 1 > income Statement > net Income
-33858000
Quarters > 1 > income Statement > eps
-0.5469576944264739
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
61902411
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-44577000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
11260000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
52446000
Quarters > 1 > balance Sheet > short Term Investments
943565000
Quarters > 1 > balance Sheet > receivables
5691000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
1005553000
Quarters > 1 > balance Sheet > property Plant Equipment
23150000
Quarters > 1 > balance Sheet > total Assets
1032212000
Quarters > 1 > balance Sheet > payables
3477000
Quarters > 1 > balance Sheet > short Term Debt
1873000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
41696000
Quarters > 1 > balance Sheet > equity
990516000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-33858000
Quarters > 1 > cash Flow > depreciation
541000
Quarters > 1 > cash Flow > change In Working Capital
3750000
Quarters > 1 > cash Flow > cash From Operations
-23813000
Quarters > 1 > cash Flow > capital Expenditures
473000
Quarters > 1 > cash Flow > cash From Investing
1562000
Quarters > 1 > cash Flow > cash From Financing
954000
Quarters > 1 > cash Flow > net Change In Cash
-21297000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.5469576944264739
Quarters > 1 > ratios > PB
0.8858682504119065
Quarters > 1 > ratios > ROE
-3.4182183831457547
Quarters > 1 > ratios > ROA
-3.2801401262531336
Quarters > 1 > ratios > FCF
-24286000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
42
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
519000
Quarters > 2 > income Statement > gross Profit
-519000
Quarters > 2 > income Statement > operating Expenses
34897000
Quarters > 2 > income Statement > operating Income
-34897000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-23508000
Quarters > 2 > income Statement > net Income
-23508000
Quarters > 2 > income Statement > eps
-0.38043931483960447
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
61791721
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-34378000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
11389000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
73743000
Quarters > 2 > balance Sheet > short Term Investments
940403000
Quarters > 2 > balance Sheet > receivables
5585000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
1023339000
Quarters > 2 > balance Sheet > property Plant Equipment
23825000
Quarters > 2 > balance Sheet > total Assets
1050772000
Quarters > 2 > balance Sheet > payables
2351000
Quarters > 2 > balance Sheet > short Term Debt
1811000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
38303000
Quarters > 2 > balance Sheet > equity
1012469000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-23508000
Quarters > 2 > cash Flow > depreciation
519000
Quarters > 2 > cash Flow > change In Working Capital
-516000
Quarters > 2 > cash Flow > cash From Operations
-17024000
Quarters > 2 > cash Flow > capital Expenditures
371000
Quarters > 2 > cash Flow > cash From Investing
-340392000
Quarters > 2 > cash Flow > cash From Financing
554000
Quarters > 2 > cash Flow > net Change In Cash
-356862000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.38043931483960447
Quarters > 2 > ratios > PB
0.8651105813363175
Quarters > 2 > ratios > ROE
-2.3218488664838133
Quarters > 2 > ratios > ROA
-2.2372122591770625
Quarters > 2 > ratios > FCF
-17395000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
42
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
-8512000
Quarters > 3 > income Statement > cost Of Revenue
512000
Quarters > 3 > income Statement > gross Profit
-9550000
Quarters > 3 > income Statement > operating Expenses
29022000
Quarters > 3 > income Statement > operating Income
-29022000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-20216000
Quarters > 3 > income Statement > net Income
-20216000
Quarters > 3 > income Statement > eps
-0.35571274921579027
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
56832374
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-28510000
Quarters > 3 > income Statement > operating Margin
340.95394736842104
Quarters > 3 > income Statement > total Other Income Expense Net
8806000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
430605000
Quarters > 3 > balance Sheet > short Term Investments
594568000
Quarters > 3 > balance Sheet > receivables
5381000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
1033666000
Quarters > 3 > balance Sheet > property Plant Equipment
24150000
Quarters > 3 > balance Sheet > total Assets
1061516000
Quarters > 3 > balance Sheet > payables
4026000
Quarters > 3 > balance Sheet > short Term Debt
1749000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
38735000
Quarters > 3 > balance Sheet > equity
1022781000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-20216000
Quarters > 3 > cash Flow > depreciation
512000
Quarters > 3 > cash Flow > change In Working Capital
-345000
Quarters > 3 > cash Flow > cash From Operations
-16725000
Quarters > 3 > cash Flow > capital Expenditures
42000
Quarters > 3 > cash Flow > cash From Investing
33926000
Quarters > 3 > cash Flow > cash From Financing
386650000
Quarters > 3 > cash Flow > net Change In Cash
403851000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.35571274921579027
Quarters > 3 > ratios > PB
0.7876553254802348
Quarters > 3 > ratios > ROE
-1.9765717196545498
Quarters > 3 > ratios > ROA
-1.9044460940767733
Quarters > 3 > ratios > FCF
-16767000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
1.9698073308270676
Quarters > 3 > health Score
52
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
10588000
Annuals > 0 > income Statement > cost Of Revenue
2060000
Annuals > 0 > income Statement > gross Profit
8528000
Annuals > 0 > income Statement > operating Expenses
107375000
Annuals > 0 > income Statement > operating Income
-98847000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-68994000
Annuals > 0 > income Statement > net Income
-68994000
Annuals > 0 > income Statement > eps
-1.2835739592658657
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
53751480
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-96787000
Annuals > 0 > income Statement > operating Margin
-933.5757461276918
Annuals > 0 > income Statement > total Other Income Expense Net
29853000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
430605000
Annuals > 0 > balance Sheet > short Term Investments
594568000
Annuals > 0 > balance Sheet > receivables
5381000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
1033666000
Annuals > 0 > balance Sheet > property Plant Equipment
24150000
Annuals > 0 > balance Sheet > total Assets
1061516000
Annuals > 0 > balance Sheet > payables
4026000
Annuals > 0 > balance Sheet > short Term Debt
1749000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
38735000
Annuals > 0 > balance Sheet > equity
1022781000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-68994000
Annuals > 0 > cash Flow > depreciation
2060000
Annuals > 0 > cash Flow > change In Working Capital
685000
Annuals > 0 > cash Flow > cash From Operations
-43814000
Annuals > 0 > cash Flow > capital Expenditures
359000
Annuals > 0 > cash Flow > cash From Investing
-258021000
Annuals > 0 > cash Flow > cash From Financing
713235000
Annuals > 0 > cash Flow > net Change In Cash
411400000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-1.2835739592658657
Annuals > 0 > ratios > PB
0.7173654008042777
Annuals > 0 > ratios > ROE
-6.74572562454719
Annuals > 0 > ratios > ROA
-6.499572309790904
Annuals > 0 > ratios > FCF
-44173000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-4.171987155270117
Annuals > 0 > health Score
33
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
8083000
Annuals > 1 > income Statement > cost Of Revenue
1955000
Annuals > 1 > income Statement > gross Profit
6128000
Annuals > 1 > income Statement > operating Expenses
79107000
Annuals > 1 > income Statement > operating Income
-72979000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-58293000
Annuals > 1 > income Statement > net Income
-58293000
Annuals > 1 > income Statement > eps
-1.324350808994935
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
44016283
Annuals > 1 > income Statement > income Tax Expense
1787105
Annuals > 1 > income Statement > EBITDA
-71024000
Annuals > 1 > income Statement > operating Margin
-902.870221452431
Annuals > 1 > income Statement > total Other Income Expense Net
14686000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
19205000
Annuals > 1 > balance Sheet > short Term Investments
324823000
Annuals > 1 > balance Sheet > receivables
2200000
Annuals > 1 > balance Sheet > inventories
-2200000
Annuals > 1 > balance Sheet > total Current Assets
349241000
Annuals > 1 > balance Sheet > property Plant Equipment
27841000
Annuals > 1 > balance Sheet > total Assets
380407000
Annuals > 1 > balance Sheet > payables
2424000
Annuals > 1 > balance Sheet > short Term Debt
1517000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
36058000
Annuals > 1 > balance Sheet > equity
344349000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-58293000
Annuals > 1 > cash Flow > depreciation
1955000
Annuals > 1 > cash Flow > change In Working Capital
-6554000
Annuals > 1 > cash Flow > cash From Operations
-50575000
Annuals > 1 > cash Flow > capital Expenditures
1850000
Annuals > 1 > cash Flow > cash From Investing
-41194000
Annuals > 1 > cash Flow > cash From Financing
59548000
Annuals > 1 > cash Flow > net Change In Cash
-32221000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-1.324350808994935
Annuals > 1 > ratios > PB
1.7448061790509048
Annuals > 1 > ratios > ROE
-16.928465016596533
Annuals > 1 > ratios > ROA
-15.323850507482776
Annuals > 1 > ratios > FCF
-52425000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-6.485834467400718
Annuals > 1 > health Score
34
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
8612000
Annuals > 2 > income Statement > cost Of Revenue
75703000
Annuals > 2 > income Statement > gross Profit
8612000
Annuals > 2 > income Statement > operating Expenses
75703000
Annuals > 2 > income Statement > operating Income
-67091000
Annuals > 2 > income Statement > interest Expense
4032000
Annuals > 2 > income Statement > pretax Income
-63059000
Annuals > 2 > income Statement > net Income
-54154000
Annuals > 2 > income Statement > eps
-1.305871277224531
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
41469631
Annuals > 2 > income Statement > income Tax Expense
-8905000
Annuals > 2 > income Statement > EBITDA
-66250000
Annuals > 2 > income Statement > operating Margin
-779.0408732001857
Annuals > 2 > income Statement > total Other Income Expense Net
4032000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
51426000
Annuals > 2 > balance Sheet > short Term Investments
275590000
Annuals > 2 > balance Sheet > receivables
700000
Annuals > 2 > balance Sheet > inventories
-700000
Annuals > 2 > balance Sheet > total Current Assets
332439000
Annuals > 2 > balance Sheet > property Plant Equipment
29365000
Annuals > 2 > balance Sheet > total Assets
364010000
Annuals > 2 > balance Sheet > payables
2159000
Annuals > 2 > balance Sheet > short Term Debt
763000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
43270000
Annuals > 2 > balance Sheet > equity
320740000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-63059000
Annuals > 2 > cash Flow > depreciation
841000
Annuals > 2 > cash Flow > change In Working Capital
4276000
Annuals > 2 > cash Flow > cash From Operations
-42922000
Annuals > 2 > cash Flow > capital Expenditures
6445000
Annuals > 2 > cash Flow > cash From Investing
58266000
Annuals > 2 > cash Flow > cash From Financing
500000
Annuals > 2 > cash Flow > net Change In Cash
15844000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-1.305871277224531
Annuals > 2 > ratios > PB
1.7648577138804016
Annuals > 2 > ratios > ROE
-16.88408056369645
Annuals > 2 > ratios > ROA
-14.877063816928107
Annuals > 2 > ratios > FCF
-49367000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-5.732350209010683
Annuals > 2 > health Score
34
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
3637000
Annuals > 3 > income Statement > cost Of Revenue
36566000
Annuals > 3 > income Statement > gross Profit
3637000
Annuals > 3 > income Statement > operating Expenses
36566000
Annuals > 3 > income Statement > operating Income
-32929000
Annuals > 3 > income Statement > interest Expense
370000
Annuals > 3 > income Statement > pretax Income
-32672000
Annuals > 3 > income Statement > net Income
-32559000
Annuals > 3 > income Statement > eps
-0.7894404346594683
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
41243137
Annuals > 3 > income Statement > income Tax Expense
-113000
Annuals > 3 > income Statement > EBITDA
-32816000
Annuals > 3 > income Statement > operating Margin
-905.3890569150399
Annuals > 3 > income Statement > total Other Income Expense Net
257000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
35582000
Annuals > 3 > balance Sheet > short Term Investments
339383000
Annuals > 3 > balance Sheet > receivables
200000
Annuals > 3 > balance Sheet > inventories
-200000
Annuals > 3 > balance Sheet > total Current Assets
377019000
Annuals > 3 > balance Sheet > property Plant Equipment
1597000
Annuals > 3 > balance Sheet > total Assets
379824000
Annuals > 3 > balance Sheet > payables
2458000
Annuals > 3 > balance Sheet > short Term Debt
194000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
13497000
Annuals > 3 > balance Sheet > equity
366327000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-32672000
Annuals > 3 > cash Flow > depreciation
113000
Annuals > 3 > cash Flow > change In Working Capital
8842000
Annuals > 3 > cash Flow > cash From Operations
-16976000
Annuals > 3 > cash Flow > capital Expenditures
1482000
Annuals > 3 > cash Flow > cash From Investing
-340963000
Annuals > 3 > cash Flow > cash From Financing
386524000
Annuals > 3 > cash Flow > net Change In Cash
28585000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.7894404346594683
Annuals > 3 > ratios > PB
1.5367931385073994
Annuals > 3 > ratios > ROE
-8.887960756373404
Annuals > 3 > ratios > ROA
-8.572128143561228
Annuals > 3 > ratios > FCF
-18458000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-5.07506186417377
Annuals > 3 > health Score
34
Valuation > metrics > PE
-0.3919954127201568
Valuation > metrics > PB
0.90029310676306
Valuation > final Score
70
Valuation > verdict
10.0% Undervalued
Profitability > metrics > ROE
-2.4896703206680626
Profitability > metrics > ROA
-2.43596243209503
Profitability > metrics > Net Margin
-2.4313
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.049368443149643386
Risk > metrics > Interest Coverage
-70.36127744510978
Risk > final Score
-221
Risk > verdict
High
Liquidity > metrics > Current Ratio
175.87418502202644
Liquidity > metrics > Quick Ratio
175.87418502202644
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
30
Prev Risks > 0
43
Prev Risks > 1
47
Prev Risks > 2
46
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:03:47.585Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-06
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-0.6998
Earnings History > 0 > eps Difference
0.6998
Earnings History > 0 > surprise Percent
100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-11
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.39
Earnings History > 1 > eps Estimate
-0.6173
Earnings History > 1 > eps Difference
0.2273
Earnings History > 1 > surprise Percent
36.8216
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-07
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.55
Earnings History > 2 > eps Estimate
-0.4612
Earnings History > 2 > eps Difference
-0.0888
Earnings History > 2 > surprise Percent
-19.2541
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-06-26
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.38
Earnings History > 3 > eps Estimate
-0.3917
Earnings History > 3 > eps Difference
0.0117
Earnings History > 3 > surprise Percent
2.987
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-02-27
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.36
Earnings History > 4 > eps Estimate
-0.4265
Earnings History > 4 > eps Difference
0.0665
Earnings History > 4 > surprise Percent
15.592
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-07
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.51
Earnings History > 5 > eps Estimate
-0.33
Earnings History > 5 > eps Difference
-0.18
Earnings History > 5 > surprise Percent
-54.5455
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-06
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.11
Earnings History > 6 > eps Estimate
-0.31
Earnings History > 6 > eps Difference
0.2
Earnings History > 6 > surprise Percent
64.5161
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-07
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.3
Earnings History > 7 > eps Estimate
-0.33
Earnings History > 7 > eps Difference
0.03
Earnings History > 7 > surprise Percent
9.0909
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-03-08
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.25
Earnings History > 8 > eps Estimate
-0.41
Earnings History > 8 > eps Difference
0.16
Earnings History > 8 > surprise Percent
39.0244
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-07
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.25
Earnings History > 9 > eps Estimate
-0.47
Earnings History > 9 > eps Difference
0.22
Earnings History > 9 > surprise Percent
46.8085
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-08
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.42
Earnings History > 10 > eps Estimate
-0.52
Earnings History > 10 > eps Difference
0.1
Earnings History > 10 > surprise Percent
19.2308
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-09
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.42
Earnings History > 11 > eps Estimate
-0.49
Earnings History > 11 > eps Difference
0.07
Earnings History > 11 > surprise Percent
14.2857
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-03-10
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.39
Earnings History > 12 > eps Estimate
-0.49
Earnings History > 12 > eps Difference
0.1
Earnings History > 12 > surprise Percent
20.4082
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-10
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.4
Earnings History > 13 > eps Estimate
-0.49
Earnings History > 13 > eps Difference
0.09
Earnings History > 13 > surprise Percent
18.3673
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-09
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.41
Earnings History > 14 > eps Estimate
-0.37
Earnings History > 14 > eps Difference
-0.04
Earnings History > 14 > surprise Percent
-10.8108
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-05-10
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.32
Earnings History > 15 > eps Estimate
-0.37
Earnings History > 15 > eps Difference
0.05
Earnings History > 15 > surprise Percent
13.5135
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-03-18
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.33
Earnings History > 16 > eps Estimate
-0.31
Earnings History > 16 > eps Difference
-0.02
Earnings History > 16 > surprise Percent
-6.4516
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-11-09
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.26
Earnings History > 17 > eps Estimate
-0.18
Earnings History > 17 > eps Difference
-0.08
Earnings History > 17 > surprise Percent
-44.4444
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-08-10
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.62
Earnings History > 18 > eps Estimate
-0.13
Earnings History > 18 > eps Difference
-0.49
Earnings History > 18 > surprise Percent
-376.9231
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-06-11
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-2.02
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
-2.02
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2021-03-31
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-2.6331
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
-2.6331
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2019-12-31
Earnings History > 21 > report Date
2020-03-31
Earnings History > 21 > date
2019-12-31
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-2.204
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
-2.204
Earnings History > 21 > surprise Percent
-
Janux Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies based on Tumor Activated T Cell Engager (TRACTr) and Tumor Activated Immunomodulator (TRACIr) platforms technology to treat patients with cancer. Its clinical candidates include JANX007, a prostate-specific membrane antigen or PSMA-TRACTr, which is in Phase 1 clinical trial in adults for the treatment of metastatic castration-resistant prostate cancer and the vasculature of other tumors; and JANX008, an epidermal growth factor receptor that is in Phase 1 clinical trial for the treatment of various solid cancers, including colorectal cancer, squamous cell carcinoma of the head and neck, non-small cell lung cancer, renal cell carcinoma, small cell lung cancer, pancreatic ductal adenocarcinoma, and triple-negative breast cancer. Janux Therapeutics, Inc. has strategic research collaboration agreement with Merck Sharp & Dohme Corp. to develop TRACTr product candidates. The company was incorporated in 2017 and is headquartered in San Diego, California.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AGains Recap: Will JANX outperform small cap indexes - 2025 Growth vs Value & Accurate Intraday Trade Tips baoquankhu1.vn
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$65.1177
Analyst Picks
Strong Buy
11
Buy
1
Hold
1
Sell
0
Strong Sell
0
Sentiment:
Neutral
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 110.39% of the total shares of Janux Therapeutics Inc
1.
RA Capital Management, LLC(18.6203%)
since
2025/06/30
2.
FMR Inc(14.7914%)
since
2025/06/30
3.
HHG PLC(7.4223%)
since
2025/06/30
4.
BlackRock Inc(5.6625%)
since
2025/06/30
5.
Paradigm Biocapital Advisors LP(4.8595%)
since
2025/06/30
6.
Adage Capital Partners Gp LLC(4.2018%)
since
2025/06/30
7.
Fidelity Growth Compy Commingled Pl S(3.6667%)
since
2025/07/31
8.
Vanguard Group Inc(3.6433%)
since
2025/06/30
9.
Point72 Asset Management, L.P.(3.5676%)
since
2025/06/30
10.
T. Rowe Price Associates, Inc.(2.9844%)
since
2025/06/30
11.
Fidelity Growth Company Fund(2.5978%)
since
2025/07/31
12.
Cormorant Asset Management, LLC(2.4961%)
since
2025/06/30
13.
EcoR1 Capital, LLC(2.4459%)
since
2025/06/30
14.
State Street Corp(2.3099%)
since
2025/06/30
15.
Woodline Partners LP(2.0667%)
since
2025/06/30
16.
Citadel Advisors Llc(2.0487%)
since
2025/06/30
17.
Orbimed Advisors, LLC(2.014%)
since
2025/06/30
18.
Vanguard Total Stock Mkt Idx Inv(1.9569%)
since
2025/07/31
19.
Franklin Resources Inc(1.7792%)
since
2025/06/30
20.
Logos Global Management LP(1.6641%)
since
2025/06/30
21.
iShares Russell 2000 ETF(1.5742%)
since
2025/08/31
22.
Geode Capital Management, LLC(1.5015%)
since
2025/06/30
23.
Bank of America Corp(1.4301%)
since
2025/06/30
24.
Prosight Management, LP(1.4209%)
since
2025/06/30
25.
Fidelity Select Health Care(1.1638%)
since
2025/07/31
26.
Fidelity Small Cap Growth(1.1591%)
since
2025/06/30
27.
US Small-Cap Growth II Equity Comp(1.0151%)
since
2025/06/30
28.
SPDR® S&P Biotech ETF(0.9513%)
since
2025/08/31
29.
T. Rowe Price New Horizons(0.8958%)
since
2025/07/31
30.
Janus Henderson Global Life Sciences(0.8617%)
since
2025/06/30
31.
Janus Henderson Global Life Sciences D(0.8617%)
since
2025/06/30
32.
Janus Henderson Triton D(0.825%)
since
2025/06/30
33.
Janus Henderson US SMID Cap Growth(0.825%)
since
2025/06/30
34.
Janus Henderson US SMID Cap Growth MA(0.825%)
since
2025/06/30
35.
Fidelity Growth Company K6(0.8039%)
since
2025/07/31
36.
Fidelity Advisor Health Care I(0.7623%)
since
2025/07/31
37.
Janus Global Life Science AUSD(0.7066%)
since
2025/06/30
38.
Janus Henderson Glb Life Scn I2 USD(0.6998%)
since
2025/07/31
39.
Fidelity Small Cap Index(0.6582%)
since
2025/06/30
40.
Fidelity Series Growth Company(0.6513%)
since
2025/07/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.6998
Date
2025-09-30
EPS Actual
-0.39
EPS Estimate
-0.6173
EPS Difference
0.2273
Surprise Percent
36.8216%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.